SA
Log In
HUMA
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
11 analysts·Moderate coverage
73
Score
10 Buy (91%)1 Hold (9%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1091%
Hold
19%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$3.00
+224.4%
Consensus
$3.00
+224.4%
Bull
$3.00
+224.4%
12-Month Target Range11 analysts
$3.00$3.00$3.00
Current $0.92Consensus
Current Price
$0.92
Upside to Consensus
$2.08

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+450.69%
EPS—
FY2028
Rev+328.14%
EPS—
FY2029
Rev+67.11%
EPS+247.07%

Earnings Surprises

Recent Analyst Actions

Dec 1, 2025H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Humacyte (HUMA)
Target:$3.00
+122.2%from $1.35
Oct 13, 2025UBS
Humacyte price target lowered to $6 from $7 at BTIG
Target:$6.00
+256.9%from $1.68
Aug 27, 2025Barclays
Humacyte initiated with an Overweight at Barclays
Target:$3.50
+138.1%from $1.47
Oct 18, 2024Piper Sandler
Piper Sandler Reiterates Neutral Rating on Humacyte (HUMA)
Target:$6.00
+23.5%from $4.86
Oct 18, 2024BTIG
BTIG Reiterates Buy Rating on Humacyte (HUMA)
Target:$10.00
+105.8%from $4.86
Dec 20, 2022Cowen & Co.
Humacyte (HUMA) Stock Gets A $5 Price Target
Target:$5.00
+126.5%from $2.21
May 15, 2022Piper Sandler
Humacyte downgraded to Underweight from Overweight at Piper Sandler
Target:$4.00
-25.5%from $5.37

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance